<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: We audited indications and outcomes of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) screening in the pregnant population at our centre </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Prospective and observational </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> APS test results returned were audited for validity of indication and subsequent outcome </plain></SENT>
<SENT sid="3" pm="."><plain>RESULT: 24 of a total of 146 (16%) of requests for the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> were not indicated </plain></SENT>
<SENT sid="4" pm="."><plain>Two positive results returned for a total of 116 "indicated" requests (1.7%) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: There needs to be increased awareness among obstetricians on the indications for screening for <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> with obstetric manefestations in the study population is lower than rates published in the literature </plain></SENT>
</text></document>